Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Low-income, Racial/Ethnic Minority Adults in a Federally Qualified Health Center
Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Low-income, Racial/Ethnic Minority Adults in a Federally Qualified Health Center
批准号:
10360762
负责人:
Inger E Burnett-Zeigler
金额:
$11.67万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-13 至 2023-03-31
关键词:
AdultAgeAntidepressive AgentsAreaBiologicalBiological MarkersChicagoChronicClinical effectivenessCognitiveCommunitiesDataDepression screenDepressive disorderDevelopmentDisadvantagedEducationEffectivenessFederally Qualified Health CenterFeedbackGoalsHealthHealth EducatorsHealth ResourcesHispanicsIncomeIndividualInflammatory ResponseInsuranceInterpersonal RelationsInterventionInterviewLeadershipLinkLow incomeMediatingMediator of activation proteinMental DepressionMental HealthMental disordersMethodsMind-Body InterventionMindfulness TrainingModelingMonitorNeighborhood Health CenterOutcomeParticipantPatientsPersonal SatisfactionPilot ProjectsPopulationPovertyPreparationPrimary Health CareQuality of lifeRandomizedRandomized Controlled TrialsResearchResearch Project GrantsSeriesStressSurveysTestingTimeTrainingUnderserved PopulationUnemploymentWomanWorkarmbasecommunity settingdaily functioningdepressive symptomsdisparity reductioneffectiveness evaluationemotional factorenvironmental stressorethnic minority populationevidence baseexperienceimplementation interventionimprovedimproved outcomeinflammatory markerinnovationinstructorintervention effectmembermindfulnessmindfulness interventionmindfulness-based stress reductionpatient populationprimary care settingpsychologicpsychological outcomesracial and ethnicrecruitreduce symptomssocialsocioeconomic disadvantageteachertreatment armtreatment as usualusual care arm
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this R01 (PA-16-160) application is to examine the clinical effectiveness of a mindfulness
intervention on reducing depressive symptoms among socio-economically disadvantaged, racial/ethnic minority
adults and explore factors related to implementation in a Federally Qualified Health Center (FQHC). This
research will be used to develop a generalizable model for delivery of streamlined mental health interventions in
community based settings that will be broadly disseminated and scalable to other populations. Black and
Hispanic adults are more likely than those who are White to receive depression treatment in primary care, where
antidepressants are the most commonly offered treatment. However, Black and Hispanic adults are less likely
than Whites to find antidepressants acceptable. A mindfulness depression intervention provided within primary
care may be more accessible and acceptable for low-income, racial/ethnic minority individuals, a severely
underserved population. Accumulating research suggests that mindfulness interventions reduce the
inflammatory response that can be triggered by stress and improves psychological outcomes. We propose to
conduct a randomized controlled trial to test the clinical effectiveness of a mindfulness intervention (M-Body) on
reducing depressive symptoms, compared to usual care, among low-income racial/ethnic minority adults in a
FQHC. In preliminary studies, women ages 18-65 with depressive symptoms were recruited from a FQHC to
participate in the 8-week, 90 minute per session M-Body intervention. The M-Body intervention is based on
Mindfulness Based Stress Reduction (MBSR) and has been tailored for the FQHC setting and patient population.
Data from four pilot groups led by the PI (N=31) and FQHC health educator (N=41) provide evidence of
acceptability, feasibility and improved depressive symptom and stress outcomes over time. Adults (N=330) with
depressive symptoms will be recruited from a FQHC in the Chicago, IL area that serves majority racial/ethnic
minority individuals (90%) living at or below the poverty line (74%). Half of the patients will be randomized to the
M-Body intervention arm where they will receive 8-weeks of mindfulness training led by FQHC staff and the other
half will be randomized to usual care. Information on factors relevant to implementation of the intervention in the
FQHC will be obtained by convening a series of workgroups and individual interviews with FQHC staff, executive
leadership and community stakeholders. Specific Aims: 1) Determine the effectiveness of a mindfulness
intervention (M-Body) on reducing depressive symptoms compared to enhanced usual care for racial/ethnic
minority adults in a Federally Qualified Health Center (FQHC); 2) Explore potential mediators (stress related
biomarkers, mindfulness) and moderators (age, personal, social, environmental stressors) of the intervention's
effect; 3) Conduct a broad assessment of organizational and individual agency factors related to preparation and
implementation of the M-Body intervention in a FQHC using a mixed methods approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Low-income, Racial/Ethnic Minority Adults in a Federally Qualified Health Center
-
批准号:10427927
-
项目类别:
-
资助金额:$4.86万
-
财政年份:2018
-
负责人:Inger E Burnett-Zeigler
-
依托单位:
Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Low-income, Racial/Ethnic Minority Adults in a Federally Qualified Health Center
-
批准号:10374048
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2018
-
负责人:Inger E Burnett-Zeigler
-
依托单位:
Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Low-income, Racial/Ethnic Minority Adults in a Federally Qualified Health Center
-
批准号:9893027
-
项目类别:
-
资助金额:$45.2万
-
财政年份:2018
-
负责人:Inger E Burnett-Zeigler
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: